NEW YORK (GenomeWeb News) – ProteoNic and Oxford Expression Technologies today said they have expanded a prior agreement to grant OET a license to use ProteoNic's UNic translation enhancing elements.

OET will use the technology in its flashBAC system for third-party recombinant protein production services. As part of the deal, ProteoNic, based in Leiden, The Netherlands, will provide technical support. Financial terms include upfront payments and royalty payments of an undisclosed amount.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.